XRAY
Research Snapshot
Static fundamentals, valuation context, and investor signals for DENTSPLY SIRONA Inc. (XRAY).
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
DCF ready
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
-16.5%
ROIC, 2.8% FCF margin
Growth
2.0%
5Y sales (revenue) CAGR
Balance sheet
1.7x
Debt/equity, 1.5x current ratio
Superinvestors
3
Top: Alex Roepers (4.1%)
Strengths to research
- 3 tracked superinvestors report a position.
- 10 annual periods are available for trend analysis.
Watchouts
- Valuation multiples are limited or unavailable.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for XRAY.
Grade D
37
/ 100
Financial Charts
No financial data available for XRAY (annual).
3 superinvestors own XRAY
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| First Eagle Investment Management First Eagle Investment Management | 15,127,933 | $175M | 0.30% | 0.0% |
| John Rogers Ariel Appreciation Fund | 6,386,815 | $74M | 0.83% | 0.0% |
| Alex Roepers Atlantic Investment Management | 610,000 | $7M | 4.12% | 0.0% |